Premium
India’s generics pharmaceutical industry has been hit over the past few years ever since the US Food and Drug Administration tightened its inspections of factories in the country.The regulator has warned many Indian drugmakers and banned several of their plants citing issues related to data fudging and manufacturing violations. Pune-based ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
